🟢 Liquidia Technologies is trading 5.5% up with no new company-specific announcement identified

Liquidia Technologies is trading 5.5% higher at $36.23 on October 19, 2026; no new company-specific announcement explains the move.

• The October 13 settlement with United Therapeutics resolved six lawsuits and preserves YUTREPIA access for PAH patients, but predates today’s move.
• The S&P 500 was up 0.50% and Nasdaq Composite 1.01% amid a technology-sector recovery; broader risk sentiment may be supportive, but is not established as the direct cause.